Home Elevian

Elevian

In operation
Series A
Anti-aging Biopharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Elevian Develops Regenerative Medicines Targeting the Root Causes of Aging. The founders of Elevian have discovered blood factors that regulate aging and stimulate the body's natural repair and regeneration mechanisms. A widely published example is GDF11, which can reduce age-related cardiac hypertrophy, accelerate skeletal muscle repair, and improve cognitive function in elderly mammals. Elevian is developing biologic therapies to modulate these blood factors, which have the potential to treat or prevent a variety of degenerative diseases and extend healthy lifespan.
Elevian, Inc.
Massachusetts,United States of America
15~50 people
July 15, 2017
info@elevian.com

Enterprise Profile

Industrial Sector
Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Skin Diseases Therapeutic Products
Application Scenarios
Biological Products Recombinant Protein